EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC 4.0

Tofacitinib in Overlapping Autoimmune and Autoinflammatory Disorders: A Case Report of a Dual Graham-Little-Piccardi-Lasseur Syndrome and Hidradenitis Suppurativa

Navid Namakizadeh Esfahani, Sepehr Boroumand Sani, Kambiz Kamyab Hesari, Sama Heidari, Kamran Balighi

Case Reports in Dermatology · 27.04.2026 · 18 (1) · 346-354

DOI: 10.1159/000552170 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Case Reports in Dermatology, online erschienen am 27.04.2026. Verfasst von Navid Namakizadeh Esfahani und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Graham-Little-Piccardi-Lassueur Syndrome (GLPLS) is an autoimmune disorder characterized by a triad of cicatricial alopecia of the scalp, non-cicatricial alopecia, and follicular eruptions in the axillae and groin. Immune system dysregulation can contribute to associations with other inflammatory diseases. Case Presentation: Here, we present a female patient with a history of scalp hair loss and follicular purulent lesions on the trunk. Biopsies from three sample sites on the scalp and trunk confirmed the diagnosis of both GLPLS and hidradenitis suppurativa (HS). Due to a limited response to previous treatments, including immunosuppressants and antibiotics, the patient was considered for tofacitinib 5 mg twice daily. After 6 months of treatment, improvement in hair loss and resolution of trunk lesions were observed. Additionally, no recurrence or adverse events were noted during a 2-year follow-up.

Conclusion

This case report underscores the likelihood of co-occurrence of two hard-to-treat disorders, both with autoimmune and autoinflammatory basis, and significant improvement of both diseases with a Janus kinase inhibitor.

Schlagwörter

Stichwörter der Autor:innen

AutoimmunityAutoinflammatoryGraham-Little-Piccardi-Lassueur SyndromeHidradenitis suppurativaJanus Kinase inhibitorTofacitinib

Autor:innen und Institutionen

  • Department of Dermatology, Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran.
  • Autoimmune Bullous Disease Research Center, Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran.
  • Department of Pathology, Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran.

Zitieren

APA

Namakizadeh Esfahani, N., Boroumand Sani, S., Kamyab Hesari, K., Heidari, S., & Balighi, K. (2026). Tofacitinib in Overlapping Autoimmune and Autoinflammatory Disorders: A Case Report of a Dual Graham-Little-Piccardi-Lasseur Syndrome and Hidradenitis Suppurativa. Case Reports in Dermatology, 18(1), 346-354. https://doi.org/10.1159/000552170

Vancouver

Namakizadeh Esfahani N, Boroumand Sani S, Kamyab Hesari K, Heidari S, Balighi K. Tofacitinib in Overlapping Autoimmune and Autoinflammatory Disorders: A Case Report of a Dual Graham-Little-Piccardi-Lasseur Syndrome and Hidradenitis Suppurativa. Case Reports in Dermatology. 2026;18(1):346-354. doi:10.1159/000552170

BibTeX
@article{NamakizadehEsfahani2026,
  author = {Namakizadeh Esfahani, Navid and Boroumand Sani, Sepehr and Kamyab Hesari, Kambiz and Heidari, Sama and Balighi, Kamran},
  title = {Tofacitinib in Overlapping Autoimmune and Autoinflammatory Disorders: A Case Report of a Dual Graham-Little-Piccardi-Lasseur Syndrome and Hidradenitis Suppurativa},
  journal = {Case Reports in Dermatology},
  year = {2026},
  volume = {18},
  number = {1},
  pages = {346--354},
  doi = {10.1159/000552170}
}
Kostenlos starten →